Opioid Treatment Surge Act
This bill establishes a retroactive annual fee for opioid manufacturers, based on the manufacturer's share of the opioid drug market.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.